Field Reimbursement Manager, Mid-Atlantic Coast

About Us

We are a global, family-owned company driven by a passion for innovation. Building on our foundational expertise in carbohydrate chemistry and cell cycle biology, we develop innovative treatments for unmet patient needs, with a focus on iron metabolism and blood-related disorders.

With 700+ employees across the UK, Ireland, the Nordics, Germany, the USA, and China
, we are committed to scientific excellence, patient care, and collaborative partnerships with the medical community.

• People-Driven – We are a family-held company built on passionate, knowledgeable people. We value integrity, open-mindedness and respect and are guided by these values in all our endeavors. We respect each individual who becomes a part of our journey, from our employees and partners to our end-users. And we recognize that the strength in all our collaborations is trust.
• Committed to Quality – Quality is our source of inspiration. Quality drives our results. It represents our aspiration for excellence and our focus on driving continual improvements. For our partners and end-users, quality must always be tangible in our products, processes and people. This way, quality is the promise we keep every day.
• Innovating for Better Lives – Innovation is essential in our quest to improve the lives of humans. We seek to address unmet needs through our expertise in iron and carbohydrate-based pharmaceuticals. We believe in a holistic and collaborative approach to research and innovation, so we work together with the scientific and medical communities to set new standards.

We have continued our growth trajectory since we launched our first product in the US, Monoferric® (ferric derisomaltose), through acquisitions, partnerships, and pipeline. Our R&D investments continue to leverage our core competencies, alongside our recent advancements in oncology supportive care.

Join us in shaping the future of patient care through innovation and collaboration.

Purpose is to establish, maintain, and grow business relationships within designated hematology oncology practices, regional hospitals, integrated delivery networks (IDNs) and other emerging key accounts in the assigned geography to enhance reimbursement and patient access to Pharmacosmos products. This individual will work in a highly collaborative environment that includes field sales, market access, and regulatory.

• Pro-actively educate provider offices on Patient Services at the regional level in targeted accounts (oncology clinic/practice, hospital, IDN, emerging customers) by strategically prioritizing high utilization accounts
• Develop a strong understanding of each account’s revenue cycle management workflow to build cross-functional relationships that support patient access to Pharmacosmos’ products.
• Assist customers in the Patient Services enrollment process using approved user guides, appropriate marketing collateral based on customer’s workflow.
• Partner with targeted hematology/oncology practices and regional health systems to track status of customer co-pay claims to ensure timely payment and a claim adjudication rate of 100%.
• Act as the subject matter expert on payer access and reimbursement by educating customers on Regional and National Payer coverage issues, coding changes and appropriate claims submission processes.
• Proactively engage with customers on appropriate resources that could help overcome access barriers.
• Integrate state step therapy exception request forms into the revenue cycle process for relevant accounts, where applicable.
• Assist with determining coverage and access options available for Pharmacosmos products.
• Work with hub and provider office to address payor reimbursement challenges by providing approved Letter of Medical Necessity template and information on each regional and National Payer’s appeals process.
• Collaborate with hub, internal Sales and Market Access teams to triage reimbursement challenges from customers.
• Collaborate with National Account, Field Reimbursement Managers to understand the needs of aggregate accounts, adhering to the strategic guidance established by the National…